Epidemiological analysis shows 147 cases of tularemia in 2024, highlighting continued risks in various federal districts.
147 human tularemia cases were registered on the territory of the Russian Federation (the relative incidence rate per 100,000 population is 0.1) in 20 regions of the country in 2024. An unfavorable epidemic situation persists in the territories of the Republic of Karelia (50 tularemia cases); an increase in the incidence was recorded in the KhantyMansi Autonomous District – Yugra (58) and in the Sverdlovsk Region (12), which accounts for 81.6 % of all cases of tularemia in the country. 31 cultures of Francisella tularensis were identified in six regions of the Russian Federation. In 2024, 937,962 people were vaccinated and revaccinated against tularemia. In 2025, the high risk of epidemic complications of tularemia will remain in the Central Federal District (Ryazan, Orel and Bryansk Regions), the Southern Federal District (Volgograd, Rostov Regions and the Republic of Crimea), the North Caucasusian Federal District (Stavropol Region), the North-Western Federal District (Arkhangelsk Region, Republic of Karelia, Nenets Autonomous District), Ural Federal District (Sverdlovsk Region and Khanty-Mansiysk Autonomy, District Yugra), Siberian Federal District (Novosibirsk and Tomsk Regions, The Republic of Altai and Altai Territory), as well as in the Donetsk and Lugansk People’s Republics, Zaporozhe and Kherson Regions.
No takes yet. Share an insight, caveat, or question.
Gaevskaya et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: